Global Nasal High Flow Market - Analysis By Type (Consumables, Devices), Addressable Market (Hospitals, Homecare): Opportunities and Forecast (2019-2024)

Date: 1 December 2019

According to a research report published by Azoth Analytics in November 2019, the Nasal High Flow Market was valued at USD 2,563.25 Million in the year 2018. Nasal High Flow therapy delivers oxygen to a patient with flow higher than that delivered traditionally in oxygen therapy. As the Nasal High Flow reduces the work of breathing in critically ill patients, it also is an emerging field where a lot of new devices have the scope to be developed such as nebulization. The further innovations in the Nasal High Flow will provide the help to the patients transition to less acute care settings, help them recover more quickly and provide solutions that can assist them to avoid more acute conditions. The market is influenced by many factors including aging, increase in respiratory diseases, rise in air pollution and demand in the homecare products. 

According to the Azoth Analytics Research Report titled “Global Nasal High Flow Market: World Market Review by Product Type (Consumables, Devices), By End User Type (Hospitals, Homecare, Others)”, leading Nasal High Flow manufacturers are focusing on more efficient advancements in the market by investing in their customers, with an emphasis on creating differentiated, innovative and value-added solutions that will help them succeed.

Nasal High Flow therapy reduces dyspnea (labored breathing or shortness of breath/breathlessness) and mouth dryness. It is easy to set up and fits a nasal cannula than an oxygen mask. It makes communication easy and comfortable for patients. Among the countries, US currently leads the nasal high flow market owing to considerable investments planned in the R&D and advancement in the devices. Also improvement in the prices has led the companies to invest more and more in exploration and advancing of the devices. There is need to develop more efficient devices which could provide ability for many patients to be treated in the home rather than hospitals.